Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Opdivo

02 4Opdivo

03 1Opdivo (Domestic + Overseas)

04 1Opdualag

05 2Opdualag

PharmaCompass

01

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

02

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

03

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

04

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

05

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

06

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

07

Brand Name : Opdualag

Nivolumab

arrow
IOPC
Not Confirmed

Brand Name : Opdualag

arrow
IOPC
Not Confirmed

Nivolumab

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 252

2021 Revenue in Millions : 0

Growth (%) : New Launch in 2022

blank

08

Brand Name : Opdualag

Nivolumab/Relatlimab-rmbw

arrow
IOPC
Not Confirmed

09

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed

10

Brand Name : Opdivo

Nivolumab

arrow
IOPC
Not Confirmed